featured
2016 Top Stories in Dermatology: Dupilumab for Atopic Dermatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Simpson, EL, Bieber T, Guttman-Yassky E, et al. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis [published online October 1, 2016]. N Eng J Med. doi: 10.1056/NEJMoa1610020.
- Tsianakas A, Stander A. Dupilumab: a milestone in the treatment of atopic dermatitis. Lancet. 2016;387(10013):4-5.
- Thaci D, Simpson EL, Beck LA, et al. Efficacy and Safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomized, placebo-controlled, dose-ranging phase 2b trial. Lancet. 2016;387(10013):40-52.